AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
-5.11%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$10.4B
AUM Growth
-$929M
(-8.2%)
Cap. Flow
-$277M
Cap. Flow
% of AUM
-2.67%
Top 10 Holdings %
Top 10 Hldgs %
43.03%
Holding
1,068
New
166
Increased
266
Reduced
450
Closed
162
Top Buys
| 1 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
$46.4M |
| 2 |
Stem
STEM
|
$28.4M |
| 3 |
Plains All American Pipeline
PAA
|
$21.2M |
| 4 |
Evercore
EVR
|
$16.7M |
| 5 |
Green Plains
GPRE
|
$15.8M |
Top Sells
| 1 |
MPLX
MPLX
|
$69.9M |
| 2 |
Universal Display
OLED
|
$47.2M |
| 3 |
Acuity Brands
AYI
|
$44.9M |
| 4 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
$40.6M |
| 5 |
Western Midstream Partners
WES
|
$39.1M |
Sector Composition
| 1 | Energy | 50.72% |
| 2 | Financials | 11.42% |
| 3 | Technology | 6.62% |
| 4 | Healthcare | 4.85% |
| 5 | Consumer Discretionary | 4.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Stoke Therapeutics
STOK
$1.13B
| $1.15M | 0.01% |
45,034
-3,317
| -7% | -$84.4K |
|
377
National Health Investors
NHI
$3.72B
| $1.14M | 0.01% |
21,327
+502
| +2% | +$26.9K |
|
378
Syndax Pharmaceuticals
SNDX
$1.47B
| $1.14M | 0.01% |
59,593
-3,948
| -6% | -$75.5K |
|
379
Keros Therapeutics
KROS
$633M
| $1.13M | 0.01% |
28,599
-2,088
| -7% | -$82.6K |
|
380
RAPT Therapeutics
RAPT
$214M
| $1.12M | 0.01% |
4,517
+400
| +10% | +$99.4K |
|
381
Trustmark
TRMK
$2.43B
| $1.11M | 0.01% |
34,483
-11,548
| -25% | -$372K |
|
382
Entergy
ETR
$39.2B
| $1.11M | 0.01% |
22,282
-1,460
| -6% | -$72.5K |
|
383
Catalyst Pharmaceutical
CPRX
$2.48B
| $1.06M | 0.01% |
200,400
-17,478
| -8% | -$92.6K |
|
384
BioXcel Therapeutics
BTAI
$55.2M
| $1.04M | 0.01% |
2,142
+115
| +6% | +$55.8K |
|
385
Procter & Gamble
PG
$375B
| $1.03M | 0.01% |
7,377
-3,522
| -32% | -$492K |
|
386
Mercury Insurance
MCY
$4.29B
| $1.02M | 0.01% |
18,359
-1,300
| -7% | -$72.4K |
|
387
Praxis Precision Medicines
PRAX
$986M
| $1.02M | 0.01% |
3,670
-160
| -4% | -$44.4K |
|
388
Crinetics Pharmaceuticals
CRNX
$3.35B
| $999K | 0.01% |
47,436
-2,080
| -4% | -$43.8K |
|
389
Vimeo
VMEO
$734M
| $988K | 0.01% |
33,650
-18,000
| -35% | -$528K |
|
|
ADAP
390
Adaptimmune Therapeutics
ADAP
$10.9M
| $985K | 0.01% |
190,550
-14,225
| -7% | -$73.5K |
|
391
Nike
NKE
$109B
| $979K | 0.01% |
6,742
+2,289
| +51% | +$332K |
|
392
CubeSmart
CUBE
$9.52B
| $978K | 0.01% |
20,175
-4,919
| -20% | -$238K |
|
393
Estee Lauder
EL
$32.1B
| $961K | 0.01% |
3,204
+2,452
| +326% | +$735K |
|
394
Monolithic Power Systems
MPWR
$41.5B
| $960K | 0.01% |
1,982
-531
| -21% | -$257K |
|
395
Fulton Financial
FULT
$3.53B
| $958K | 0.01% |
62,674
| – | – |
|
396
Kiniksa Pharmaceuticals
KNSA
$2.65B
| $957K | 0.01% |
83,983
+41,412
| +97% | +$472K |
|
397
Akero Therapeutics
AKRO
$3.58B
| $955K | 0.01% |
42,729
-3,143
| -7% | -$70.2K |
|
|
AAT
398
American Assets Trust
AAT
$1.28B
| $922K | 0.01% |
24,626
| – | – |
|
399
Zebra Technologies
ZBRA
$16B
| $914K | 0.01% |
1,772
-336
| -16% | -$173K |
|
400
AnaptysBio
ANAB
$613M
| $912K | 0.01% |
33,623
-2,422
| -7% | -$65.7K |
|